Michael R. Shanks

FDA investigator

Appears on 27 documents from 2017 to 2024, most often at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

27
Documents on file
3.1
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 82 observations

Activity by year

2017: 1, 2018: 3, 2019: 4, 2020: 1, 2021: 4, 2022: 7, 2023: 5, 2024: 2

Where

California 5 · India 5 · Germany 2 · Indiana 2 · Italy 2 · South Korea 2

Often inspects with

Arsen Karapetyan· Zhong Li· Yi Wang

Is Michael R. Shanks coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

27 documents, newest first
FirmOpen
483 BioConnection B.V.Mar 8, 2024 · Oss, Netherlands
483 Alvotech HfJan 19, 2024 · Reykjavik, Iceland
483 Patheon Biologics Australia Pty LtdOct 17, 2023 · Woolloongabba, Australia
483 Roche Diagnostics GmbHMar 10, 2023 · Penzberg, Germany
483 Genentech, Inc.Feb 2, 2023 · South San Francisco, California
483 Tanvex BioPharma USA, IncJan 24, 2023 · San Diego, California
483 Form 483 · FEI 3004575449Jan 16, 2023 · San Diego, California

About this profile

What does Michael R. Shanks inspect?

Michael R. Shanks appears on 27 documents on file covering 23 sites, most often in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.22 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michael R. Shanks is dated Mar 8, 2024.